Year: 2026

SINGAPORE, March 04, 2026 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that it has repurchased and cancelled in full the warrant previously issued to Streeterville Capital, LLC. Background of the Warrant As previously disclosed, the Company entered into a securities purchase agreement dated November 26, 2025 with an accredited investor for the purchase of a warrant that was immediately exercisable into up to 2,000,000 newly issued ordinary shares of the Company. The warrant was previously amended on December 16, 2025 and January 13, 2026. Repurchase and Cancellation On February 27, 2026, the Company repurchased the warrant in full for a total purchase price of US$125,000....

Netanya, Israel, March 04, 2026 (GLOBE NEWSWIRE) — Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and developer of ruggedized tactical communication headset devices, today announced that it has won a competitive government tender in Asia, valued at approximately $400,000 for its advanced tactical protective systems. The tender is for a military force in the region and is designated for deployment with active military units. The tender is for Silynxcom’s combat-proven in-ear headset solutions, which provide industry-leading hearing protection combined with clear two-way communication and full situational awareness in high-noise combat environments. Key features of the selected in-ear systems include:Superior active and passive noise reduction to safeguard against hazardous impulse and continuous...

SAN ANTONIO, March 04, 2026 (GLOBE NEWSWIRE) — Usio, Inc. (Nasdaq:USIO), a leading provider of integrated, cloud-based electronic payment and embedded financial solutions, today announced it will release financial results for the fourth quarter and fiscal year ended December 31, 2025, after the market closes on Wednesday, March 18, 2026. Usio’s management will host a conference call the same day, March 18, 2026, beginning at 4:30 p.m. Eastern time to review financial results and provide a business update. Following management’s formal remarks, there will be a question-and-answer session. To listen to the conference call, interested parties within the U.S. should call 1-844-883-3890. International callers should call 1-412-317-9246. All callers should ask for the Usio conference call. The conference call will also be available through...

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE ON 4 MARCH 2026 AT 16.00 P.M. EET, OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCANGE Oma Savings Bank Plc’s repurchase and cancellation of its outstanding covered Bond Notes Oma Savings Bank Plc (OmaSp or the Company) has repurchased its outstanding covered bond notes maturing in 2026, in the aggregate nominal amount of EUR 50,000,000. The aim of the transaction is to optimize the Company’s financing structure. The Company has cancelled the acquired notes. The repurchases will reduce OmaSp’s interest expenses and financing risk, as well as strengthen its credit profile. The Company does not intend to carry out further repurchases and aims to maintain the outstanding nominal amount of the bond notes at EUR 500,000,000. Following the cancellation of the repurchased notes, the outstanding...

Phase 3 study designed with total hip BMD primary endpoint assessed at 12 months, rather than at 24 months EB613 single tablet final commercial formulation (Next-Gen EB613) replaces multi-tablet EB613 as Phase 3 candidate, following successful bridging study Topline data anticipated in the second half of 2028, approximately one year earlier than previously expected; Entera commits to a 12-month extension study to run in parallel with potential NDA review TEL AVIV, March 04, 2026 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptide and protein replacement therapies, today announced the submission to the U.S. Food and Drug Administration (FDA) of a clinical amendment providing a streamlined Phase 3 protocol, statistical analysis plan (SAP),...

Ongoing Service Highlights a Decade of Exceptional Quality, Support and Trust HUNTSVILLE, Ala., March 04, 2026 (GLOBE NEWSWIRE) — Lakeland Industries, Inc. (“Lakeland Fire + Safety” or “Lakeland”) (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced that its Arizona PPE Recon, Inc. (“Arizona PPE”) subsidiary, which specializes in personal protective equipment (PPE) care and maintenance services, has marked a milestone with the City of Phoenix, Arizona Fire Department (“Phoenix Fire Dept.”) for ongoing PPE advanced decontamination, inspection and repair services for the 10th consecutive year. The Phoenix Fire Dept. employs over 1,900 sworn firefighters and more than 400 civilian personnel. As one of the busiest departments...

Wichita County, Texas, field expected to quickly meet or exceed BOE/day target CONROE, Texas, March 04, 2026 (GLOBE NEWSWIRE) — via IBN — Olenox Industries Inc. (NASDAQ: OLOX) (“Olenox” or the “Company”), a multifaceted energy company, today announces the Company’s well revitalization efforts are achieving success and hitting production targets. Going forward, the Company plans to bring additional wells into production on a weekly basis. Since December 2025, the Company has successfully revitalized 10 wells, with 25 more expected to be online by the end of the first quarter. Olenox deployed a dedicated rig in its Wichita field in December 2025, and the Company is pleased with the results in the few months since deployment, according to Olenox CEO Michael McLaren. “We are pleased with the progress of our workovers and revitalization...

THE WOODLANDS, TX, March 04, 2026 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that Nikola Cesarovic, PhD, will present clinical feasibility and outcome data at the Cardiovascular Research Technologies (CRT) 2026 Meeting, happening March 7-10, 2026, in Washington, DC. The abstract titled, “Novel Technique For Transvascular Peripheral Nerve Neurolysis Using Radiofrequency (RF) Ablation: Clinical Feasibility And Outcomes,” will be presented during the Top Abstract Session (S194) on Saturday, March 7 from 2:18 – 2:24p ET for Hypertension Therapies and Renal Denervation session. Dr. Cesarovic will deliver a six-minute presentation, highlighting clinical feasibility and early outcomes...